Business Context and Reporting Period
This Form 8-K was filed by Foresight Acquisition Corp. regarding a proposed business combination with P3 Health Group Holdings, LLC (“P3”). The transaction agreements were entered into on May 25, 2021; the report was signed June 1, 2021. P3 Health Partners Inc. is not the registrant named in the filing; the registrant is Foresight Acquisition Corp.
Foresight and P3 proposed an “Up-C” transaction under which P3 would merge into a wholly owned subsidiary of Foresight, with Foresight becoming the sole manager and owning approximately 30% of the surviving company immediately after closing. The transaction was subject to stockholder, regulatory, financing and other closing conditions and had not closed as of the filing.
Key Financial and Transaction Metrics
- Implied merger consideration: $2.126 billion.
- Equity consideration: 181,104,693 common units of the surviving company, valued at $10 per unit, assuming no redemptions and $208.7 million of PIPE proceeds.
- Cash consideration: $314.953 million, subject to reduction if post-closing net cash is below $180 million. Any reduction would be replaced with additional equity consideration so that total merger consideration remains $2.126 billion.
- PIPE financing: 20,870,307 shares of Foresight Class A common stock at $10 per share, for aggregate proceeds of $208.703 million, subject to customary conditions and substantially concurrent closing of the transaction.
- Minimum available cash condition: At least $400 million of aggregate cash held by Foresight and the surviving company after specified expenses, redemptions and financing transactions.
- Ownership and governance: Foresight was expected to own approximately 30% of the surviving company and serve as its sole manager. The filing does not provide operating revenue, profit, cash-flow, margin, debt or liquidity figures for P3 or Foresight beyond the transaction-related amounts described above.
Material Changes Versus the Prior Comparable Period
The filing is a transaction announcement rather than a periodic financial report. It does not present comparative financial statements or quantify changes in revenue, earnings, cash flow, margins, debt or other operating metrics versus a prior period.
The material change disclosed is Foresight’s entry into definitive merger, blocker, sponsor-support and PIPE subscription agreements to combine with P3 and transition from a special purpose acquisition company structure to a public operating-company structure.
Guidance, Outlook, Risks and Unusual Items
- Closing was targeted no later than November 21, 2021, subject to a possible 90-day extension related to SEC warrant-accounting matters.
- Required steps included Foresight stockholder approval, regulatory approvals and filings, satisfaction of the $400 million available-cash condition, delivery of PCAOB-audited P3 financial statements and accuracy of the parties’ representations and warranties.
- Foresight planned to solicit stockholder approval through a proxy statement and pursue an exchange offer or amendment of its outstanding warrants.
- The transaction contemplated creation of Class V common stock with voting rights but no economic rights. Class V shares would be paired with surviving-company common units and could be exchanged, together with those units, for Foresight Class A common stock or cash at Foresight’s option.
- Foresight was required to pay P3 a $5 million termination fee in specified circumstances involving a superior transaction proposal or certain breaches of non-solicitation obligations.
- Additional unusual or potentially dilutive arrangements included the PIPE issuance, conversion of Foresight Class B shares into Class A shares, warrant-linked unit issuance, tax receivable agreement payments and registration rights and lock-ups.
- Risks included failure to obtain approvals, redemption levels reducing available cash, inability to complete the PIPE, uncertainty in P3’s projected financial information, regulatory and litigation risks, competition, growth execution and possible warrant-accounting consequences.
Important Facts for Investors to Verify
- Confirm whether the proposed transaction ultimately closed, its closing date and the final post-closing ownership percentages.
- Verify final redemptions, PIPE proceeds, available cash and the resulting mix of cash and equity consideration.
- Review P3’s audited financial statements and compare them with the unaudited financial information referenced in the agreement.
- Assess the final number of Class A, Class V and surviving-company common units, including dilution from warrants and other securities.
- Review the definitive proxy statement, warrant exchange or amendment documents, tax receivable agreement and registration rights and lock-up terms.
- Confirm whether the $400 million minimum-cash condition, Hart-Scott-Rodino requirements and other closing conditions were satisfied or waived.